Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of VLDLR mRNA | increases expression | 19933214
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of VLDLR mRNA | affects expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of VLDLR mRNA | affects expression | 15030884 17562736
|
C103505 |
AM 251 |
AM 251 results in increased expression of VLDLR mRNA | increases expression | 16500647
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of VLDLR mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of VLDLR mRNA | increases expression | 20458559
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of VLDLR mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VLDLR mRNA | decreases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of VLDLR mRNA | increases expression | 12075121
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of VLDLR protein | increases expression | 12629582
|
D003035 |
Cobalt |
[tungsten carbide binds to Cobalt] which results in increased expression of VLDLR mRNA | affects binding|increases expression | 20105288
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased expression of VLDLR mRNA | increases expression | 20105288
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] | decreases expression|decreases reaction | 11007951
|
D016572 |
Cyclosporine |
Cyclosporine affects the expression of VLDLR mRNA | affects expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of VLDLR mRNA | decreases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of VLDLR mRNA | decreases expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of VLDLR mRNA | increases expression | 15901920 12075121
|
D005473 |
Fluoxetine |
Fluoxetine results in increased expression of VLDLR protein | increases expression | 19359144
|
D005485 |
Flutamide |
Flutamide analog results in increased expression of VLDLR mRNA | increases expression | 17702527
|
D005485 |
Flutamide |
Flutamide results in increased expression of VLDLR mRNA | increases expression | 17702527
|
C001277 |
geldanamycin |
geldanamycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | decreases expression|decreases reaction | 15808840
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of VLDLR mRNA | increases expression | 17039268
|
D019833 |
Genistein |
Genistein results in increased expression of VLDLR mRNA | increases expression | 12075121
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of VLDLR protein | increases expression | 19359144
|
C020754 |
herbimycin |
herbimycin inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | decreases expression|decreases reaction | 15808840
|
C005219 |
methyl cellosolve |
methyl cellosolve results in increased expression of VLDLR mRNA | increases expression | 19643169
|
C035359 |
monorden |
monorden inhibits the reaction [IL1B protein results in decreased expression of VLDLR protein] | decreases expression|decreases reaction | 15808840
|
C076029 |
olanzapine |
olanzapine results in increased expression of VLDLR protein | increases expression | 19359144
|
C041786 |
palm oil |
palm oil results in decreased expression of VLDLR mRNA | decreases expression | 18042831
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of VLDLR mRNA | increases expression | 17681415
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of VLDLR mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of VLDLR mRNA | affects expression | 19136022
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of VLDLR mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VLDLR mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of VLDLR mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of VLDLR mRNA | increases expression | 18301758 17426115 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of VLDLR mRNA] | increases expression|increases reaction | 17950772
|
C009159 |
rapeseed oil |
rapeseed oil affects the expression of VLDLR mRNA | affects expression | 16177195
|
D012402 |
Rotenone |
Rotenone results in increased expression of VLDLR mRNA | increases expression | 17702527
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of VLDLR mRNA | increases expression | 17403546
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of VLDLR mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of VLDLR mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of VLDLR mRNA | increases expression | 19933214 16960034 18372398 16120747 19465110
|
C002802 |
tungsten carbide |
[tungsten carbide binds to Cobalt] which results in increased expression of VLDLR mRNA | affects binding|increases expression | 20105288
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of VLDLR mRNA | decreases expression | 19359144
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of VLDLR protein | decreases expression | 19359144
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.16 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methyl cellosolve |
17.25 | 3652986 6499812 6474471 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
17.25 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
17.25 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
17.25 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.59 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.18 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.55 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.26 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.26 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.26 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.26 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.84 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.84 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.08 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.08 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.08 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.84 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.62 | 11748828 |
MESH:D000748 |
Anemia, Macrocytic |
|
methyl cellosolve |
5.96 | 3699323 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.46 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
8.33 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.33 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.70 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.67 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.67 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.43 | 15885639 |
MESH:D053627 |
Asthenozoospermia |
|
methyl cellosolve |
5.14 | 3987992 |
MESH:D001284 |
Atrophy |
|
methyl cellosolve |
4.83 | 2626667 3699323 6705890 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15820235 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
3.35 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
3.35 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
3.35 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
3.35 | 18685284 17069543 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
3.35 | 18558336 18316065 15238991 17157402 18940202 17507914 18985861 20603192 16609825 18775368 19460635 17688650 19232924 18177632 18396377 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.63 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.88 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.31 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.31 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.31 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.20 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.20 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.52 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.38 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.38 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cobalt |
4.38 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.38 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
4.38 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.38 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.38 | 19011961 18984771 16873071 19200415 21138602 18855134 20390343 18997820 19288272 19244106 17049068 19189210 15668708 19142967 20859285 20135344 19487384 19155303 19410462 17242785 17440819 18821012 16273361 20065188 16202921 17261762 19059307 19066611 19084267 18629630 18425577 17893378 18815881 19103187 20005174 19221464 19289846 11161223 16818667 20544844 18351453 19189212 19115204 15565566 21152245 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.38 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.98 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.41 | 10355542 16192424 16124888 16050911 16011737 15673190 15700767 16227642 16097048 3786805 18705752 15721981 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.50 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.13 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
12.98 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
12.98 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
12.98 | 15073043 16217749 15553829 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
12.98 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
12.98 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
12.98 | 17173139 1701930 20007298 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
12.98 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.61 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.49 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.49 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.79 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
1.94 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.29 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.04 | 16332659 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.53 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.36 | 10977129 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.86 | 16772815 18071103 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
9.61 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.61 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
9.61 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.88 | 4080065 |
OMIM:224050 |
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1 |
marker/mechanism |
|
| |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.56 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
methyl cellosolve |
5.41 | 6499794 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
16.90 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.90 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.90 | 17681005 17333356 16105132 17110522 16919318 11677210 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.90 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.94 | 16354765 15668235 12621046 15340226 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.22 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.85 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
methyl cellosolve |
8.37 | 12530607 6499821 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.37 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.82 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.50 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.50 | 16575769 8888407 17688650 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
9.75 | 15213294 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
9.75 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.24 | 11575062 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.99 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
4.33 | 15014590 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.06 | 11298694 12868966 8970840 2524372 14531868 11906362 18759878 8156756 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
6.06 | 16823706 11298694 15059100 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.14 | 3621924 2952479 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.43 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
3.98 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.98 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.16 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
10.66 | 7440962 18648102 6679447 11289319 16192314 6482804 9022650 9653073 1440618 18289764 18692083 9328219 8291058 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
10.66 | 11743745 19923254 14550746 17562736 12540782 11834606 12153990 12958197 18713872 16081117 19416960 12594235 11739529 16109766 14725611 10663392 16781746 11421492 11529661 16393943 11461765 12392966 2444490 11287661 19739265 19420014 19370779 17522070 15968718 19085960 18071297 19164858 17906064 12705907 16177239 10915739 14986274 16485898 15619225 16227642 10774834 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
10.66 | 17522070 7440962 11566570 10092053 15998439 16177239 4309450 2869522 3786805 16227642 19336974 21278145 6623471 7179309 15968718 3732212 7120509 10915739 6884620 15027814 9327722 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.66 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
10.66 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.71 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.18 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
9.27 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
9.27 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
13.74 | 12798668 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
13.74 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
13.74 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.74 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.51 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.75 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.75 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.21 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
6.69 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.69 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.69 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
9.55 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
9.55 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
8.68 | 11558140 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
8.68 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.99 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.99 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
7.80 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
7.80 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.06 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
10.06 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.21 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
9.21 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.46 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.46 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
9.46 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.46 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
37.38 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
37.38 | 16045604 17595544 61145 16239168 19224547 15959796 12795759 12631006 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
37.38 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
37.38 | 18296743 19551842 19004024 17967931 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
37.38 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
37.38 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
37.38 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
37.38 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.00 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.77 | 18558336 8888407 |
MESH:D005327 |
Fetal Resorption |
|
methyl cellosolve |
5.16 | 6499821 6499812 3987992 6474471 |
MESH:D020567 |
Fetal Weight |
|
methyl cellosolve |
5.41 | 6474471 6499812 6499821 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.63 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.15 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.80 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
18.07 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
18.07 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
18.07 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
18.07 | 20067830 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methyl cellosolve |
5.12 | 3652986 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.90 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.29 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.84 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.01 | 16598420 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.69 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.76 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.76 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006345 |
Heart Septal Defects, Ventricular |
|
methyl cellosolve |
5.40 | 6499821 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.04 | 15720958 |
MESH:D006461 |
Hemolysis |
|
methyl cellosolve |
5.07 | 17874071 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.02 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.02 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
17.64 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
17.64 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
17.64 | 18467677 19176532 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
17.64 | 12621046 15340226 16120746 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
4.92 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.48 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 18606429 15340226 16959395 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.87 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.87 | 12083418 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
5.07 | 15356085 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.15 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.26 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.27 | 21332399 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.85 | 17933447 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.57 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cobalt |
7.82 | 17039479 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.82 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.82 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.72 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.44 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.11 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.20 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
methyl cellosolve |
6.20 | 3987992 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
13.70 | 20412841 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
13.70 | 12798668 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
13.70 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
13.70 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.70 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
10.88 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
10.88 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.88 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.63 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.05 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.05 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.59 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.59 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
10.59 | 18625569 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.78 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
5.78 | 18980019 17468513 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.46 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.93 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.15 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.42 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.64 | 20471514 16968895 17050201 19850784 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.64 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.96 | 17869043 19642359 15622746 15213294 12679006 12712474 16966277 17107899 19075265 11468182 19225113 19035177 9834237 16330433 16891316 16112521 12018890 11161223 15748426 16331271 17712046 17217047 16823087 17649720 15336539 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.99 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.85 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methyl cellosolve |
4.22 | 6499821 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
7.43 | 17567588 15342952 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.43 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
9.77 | 17334410 11903743 16239168 17157831 16221502 11408273 17174718 16943688 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
9.77 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
9.77 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.96 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.14 | 15673190 17869086 17640975 16027843 17557913 12666154 12898905 18277467 15730626 15925388 18376398 15052691 15338365 15931870 12667390 16097048 18418968 17766677 13678700 18054572 18412020 16015684 12445421 18205269 12546737 17823541 17525996 18420326 18210741 17922224 12958196 18481824 17708605 15818738 17805973 15123356 16248980 17976157 18156304 18166357 18395914 17565644 18251166 15370692 15876570 17761835 12632514 18263696 17714472 16033810 14716496 16638106 12649538 18006644 18317297 16136751 10355542 14748882 16011737 18395095 17721639 12632512 16192424 17631135 18429990 12445418 18279442 18472332 15996030 12609069 12741479 15057751 14724832 18705752 15650968 18472094 15959796 15893842 16116963 14716833 12586293 20821823 17481882 15362042 14512876 18339082 17944888 14620537 18187930 17698563 12389079 11481614 17900296 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.14 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.14 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.14 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.14 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.83 | 11587558 12969438 12587719 16611625 19014921 19784758 19460945 16610002 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.83 | 16964402 15720792 16246199 15830285 17285989 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
5.83 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.79 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.31 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.31 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
23.22 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
23.22 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
23.22 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
23.22 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
23.22 | 19812893 8742319 19482888 15975961 19073162 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
23.22 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
23.22 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.22 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
16.08 | 6587162 1399818 3712494 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
16.08 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
16.08 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
16.08 | 2563599 1399818 18308698 17172636 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.08 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
7.66 | 15213294 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
7.66 | 20210726 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.87 | 17228818 |
MESH:D008173 |
Lung Diseases, Obstructive |
|
Cobalt |
5.49 | 6434250 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.39 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.39 | 20064080 17053015 20135361 18569708 20869020 20464547 18816296 18520028 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.39 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.39 | 11884234 19555203 |
MESH:D008231 |
Lymphopenia |
|
methyl cellosolve |
5.40 | 3699323 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.38 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
5.29 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.29 | 19196723 14580682 11731420 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.16 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.83 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.80 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.20 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
11.34 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
11.34 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
11.34 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.05 | 19142110 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.40 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.92 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.90 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.84 | 15949261 19417148 14977855 19549372 11468182 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.69 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.28 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.68 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.68 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.12 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.12 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.42 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.42 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.09 | 17484760 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.50 | 8041377 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.60 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.15 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.15 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.18 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.18 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.61 | 19200415 19189210 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.97 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.59 | 15790535 18619942 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.31 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
14.31 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
10.68 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.68 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
10.68 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.56 | 18514411 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.58 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.94 | 18674790 17217161 20132043 18457598 20518802 16723640 11836018 19632207 21332399 |
MESH:D009765 |
Obesity |
|
olanzapine |
6.94 | 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.94 | 20558911 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
5.10 | 20418887 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.09 | 4026338 6482804 |
MESH:D009845 |
Oligospermia |
|
methyl cellosolve |
4.80 | 3987992 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.63 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.98 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.02 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.74 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.61 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.53 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
4.53 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.81 | 16870215 |
MESH:D010146 |
Pain |
|
AM 251 |
9.81 | 18987195 |
MESH:D010146 |
Pain |
|
Fluoxetine |
9.81 | 12798668 |
MESH:D010190 |
Pancreatic Neoplasms |
|
AM 251 |
11.23 | 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.23 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
11.23 | 18992248 11504793 16929163 17440100 18383843 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.23 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.34 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.11 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.81 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.83 | 19114014 16412576 18191903 11445065 16140633 11535288 15451049 18619942 19232380 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.75 | 15927086 15574749 15795934 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.08 | 6228378 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.63 | 8041377 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.67 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.91 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
7.91 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
26.42 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
methyl cellosolve |
26.42 | 7974496 12530607 6499817 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
26.42 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
26.42 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
26.42 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.88 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
1.88 | 3169114 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.88 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.88 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.93 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.90 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.90 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.09 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
10.58 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
10.58 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
3.98 | 11575062 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.40 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cobalt |
3.85 | 6434250 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.09 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.82 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.60 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.41 | 19369910 20107430 1830565 18513383 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
5.41 | 20521326 20107430 17726453 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
5.41 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.14 | 3137016 11442880 4039156 16876388 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.14 | 11044598 11738929 3137016 14763951 15475178 16876388 17978042 1511512 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.44 | 6407741 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.51 | 8704074 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
4.85 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
4.85 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.27 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.27 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.66 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.49 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.15 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.26 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.26 | 20155912 2093021 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.60 | 16684133 16045194 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
9.75 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
9.75 | 20210726 |
MESH:D013733 |
Testicular Diseases |
|
methyl cellosolve |
4.71 | 6499806 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.27 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.83 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.30 | 1399818 3712494 6587162 6582329 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
10.30 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
10.30 | 1399818 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.58 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.84 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.14 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.59 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
10.59 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
10.59 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
10.59 | 8653321 17572228 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.63 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.62 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.94 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.60 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
9.02 | 16723640 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
9.02 | 20107430 17933447 19434072 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.05 | 17120751 |